CCL2 and ischemia: The present protein analyses and results strongly support the hypothesis that catalpol exerts its anti-inflammatory, antioxidative, and anti-ischemic/hypoxic properties via mechanisms of downregulating the ischemia-associated overexpression of MCP-1, β-catenin, HIF-1α, VEGF, and angiopoietin-2.